Skip navigation
Agenda

Evaluate the Impact of Shifting Reimbursement Models on Patient Access, Outcomes and Overall Oncology Costs

October 3-4, 2019
  • Scottsdale, AZ

Agenda

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, OCTOBER 3, 2019

8:00

Pre-Conference Workshop Registration and Continental Breakfast

9:00

Workshop Leader’s Welcome and Opening Remarks

Advancing Palliative Care to Drive Better Patient Outcomes and Manage Costs

Workshop Objective:

This workshop examines the role that palliative care programs can play in the cancer care continuum and the progress made to date to ensure that palliative care is accurately defined among healthcare professionals and cancer patients allowing for optimum treatment decisions.

Workshop Outline:

I. Examine the Current State of Palliative Care and Barriers to Implementation

II. Review the Impact of Shifting Payment Models on Palliative Care

III. Understand Payer Perspectives on Promoting Palliative Care Initiatives

IV. Discuss the Role of Predictive Analytics in Palliative Care

V. End-of-Life Strategies and Advance Care Directives

Workshop Leaders:

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

Jeremy Powell
CEO
Acclivity Health Solutions

There will be a 30 minute networking and refreshment break at 10:00am

12:00

Networking Luncheon for Workshop Participants

12:00

Conference Registration

1:00

Day One Chairman’s Welcome & Opening Remarks

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

1:15

PANEL DISCUSSION Assess the Current State of Oncology Payment Models

MODERATOR:

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

PANELISTS:

Anthony V. Coletta, MD, MBA
CEO and Chairman of the Board
Tandigm Health a wholly owned subsidiary of Independence Blue Cross

Aaron Lyss
Director, Value-based Care
Tennessee Oncology

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care, Assistant Professor of Pharmacy
Mayo Clinic

2:15

Provider Readiness to Accept Risk in Value-Based Contracts — Lessons Learned

Anthony V. Coletta, MD, MBA
CEO and Chairman of the Board
Tandigm Health a wholly owned subsidiary of Independence Blue Cross

3:00

Networking and Refreshment Break

3:30

Managing the Business of Oncology as Risk-Based Reimbursement Models Rise

Aaron Lyss
Director, Value-based Care
Tennessee Oncology

4:15

Preparing for a Mandatory Alternative Payment Model for Radiation Oncology

Anne Hubbard, MBA
Director of Health Policy
The American Society for Radiation Oncology

5:00

INTERACTIVE Q&A SESSION Understand Payer Perspectives on the Future of Oncology Management

INTERVIEWER:

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

Jonathan Harding, MD
Senior Medical Director, Senior Products Division
Tufts Health Plan

Steven Peskin
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey

5:45

Close of Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, OCTOBER 4, 2019

7:45

Continental Breakfast

8:15

Day Two Chairman’s Opening Remarks

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

8:30

Demystify the Complexity of Implementing Value-Based Oncology Programs — An Approach for Health Plans

Steven Peskin
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey

9:10

Biosimilars — Impact on Oncology Practice

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care, Assistant Professor of Pharmacy
Mayo Clinic

9:50

INTERACTIVE SESSION Case Study — Understand the Cancer Care Patient Treatment Journey

Jonathan Harding, MD
Senior Medical Director, Senior Products Division
Tufts Health Plan

10:35

Networking and Refreshment Break

11:05

Transitioning from Patient Billing to Patient Engagement

David Frederiksen
CEO & Founder
PatientFocus

11:45

Understand Key Drivers to Engage in Downside Risk Models

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

12:30

Networking Luncheon

1:30

Examine the Effect of Comprehensive Genomic Profiling (CGP) on Decision Impact, Clinical Trial Enrollment and Costs

Stella Stergiopoulos
Associate Director, Health Economic Outcomes Research and Payer Policy
Foundation Medicine, Inc.

2:15

Specialty Pharmacy’s Evolving Role in Oncology Management

Nick Calla
Vice President, Pharma Relations
BioMatrix Specialty Pharmacy

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, OCTOBER 3, 2019

8:00

Pre-Conference Workshop Registration and Continental Breakfast

9:00

Workshop Leader’s Welcome and Opening Remarks

Advancing Palliative Care to Drive Better Patient Outcomes and Manage Costs

Workshop Objective:

This workshop examines the role that palliative care programs can play in the cancer care continuum and the progress made to date to ensure that palliative care is accurately defined among healthcare professionals and cancer patients allowing for optimum treatment decisions.

Workshop Outline:

I. Examine the Current State of Palliative Care and Barriers to Implementation

II. Review the Impact of Shifting Payment Models on Palliative Care

III. Understand Payer Perspectives on Promoting Palliative Care Initiatives

IV. Discuss the Role of Predictive Analytics in Palliative Care

V. End-of-Life Strategies and Advance Care Directives

Workshop Leaders:

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

Jeremy Powell
CEO
Acclivity Health Solutions

There will be a 30 minute networking and refreshment break at 10:00am

12:00

Networking Luncheon for Workshop Participants

12:00

Conference Registration

1:00

Day One Chairman’s Welcome & Opening Remarks

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

1:15

PANEL DISCUSSION Assess the Current State of Oncology Payment Models

MODERATOR:

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

PANELISTS:

Anthony V. Coletta, MD, MBA
CEO and Chairman of the Board
Tandigm Health a wholly owned subsidiary of Independence Blue Cross

Aaron Lyss
Director, Value-based Care
Tennessee Oncology

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care, Assistant Professor of Pharmacy
Mayo Clinic

2:15

Provider Readiness to Accept Risk in Value-Based Contracts — Lessons Learned

Anthony V. Coletta, MD, MBA
CEO and Chairman of the Board
Tandigm Health a wholly owned subsidiary of Independence Blue Cross

3:00

Networking and Refreshment Break

3:30

Managing the Business of Oncology as Risk-Based Reimbursement Models Rise

Aaron Lyss
Director, Value-based Care
Tennessee Oncology

4:15

Preparing for a Mandatory Alternative Payment Model for Radiation Oncology

Anne Hubbard, MBA
Director of Health Policy
The American Society for Radiation Oncology

5:00

INTERACTIVE Q&A SESSION Understand Payer Perspectives on the Future of Oncology Management

INTERVIEWER:

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

Jonathan Harding, MD
Senior Medical Director, Senior Products Division
Tufts Health Plan

Steven Peskin
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey

5:45

Close of Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, OCTOBER 4, 2019

7:45

Continental Breakfast

8:15

Day Two Chairman’s Opening Remarks

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

8:30

Demystify the Complexity of Implementing Value-Based Oncology Programs — An Approach for Health Plans

Steven Peskin
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey

9:10

Biosimilars — Impact on Oncology Practice

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care, Assistant Professor of Pharmacy
Mayo Clinic

9:50

INTERACTIVE SESSION Case Study — Understand the Cancer Care Patient Treatment Journey

Jonathan Harding, MD
Senior Medical Director, Senior Products Division
Tufts Health Plan

10:35

Networking and Refreshment Break

11:05

Transitioning from Patient Billing to Patient Engagement

David Frederiksen
CEO & Founder
PatientFocus

11:45

Understand Key Drivers to Engage in Downside Risk Models

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

12:30

Networking Luncheon

1:30

Examine the Effect of Comprehensive Genomic Profiling (CGP) on Decision Impact, Clinical Trial Enrollment and Costs

Stella Stergiopoulos
Associate Director, Health Economic Outcomes Research and Payer Policy
Foundation Medicine, Inc.

2:15

Specialty Pharmacy’s Evolving Role in Oncology Management

Nick Calla
Vice President, Pharma Relations
BioMatrix Specialty Pharmacy

3:00

Close of Conference